It's typically a given that undervalued stocks come with a “but”. In other words, there's usually a reason that a stock is trading below fair value and it's up to investors to decide if the prevailing sentiment is overlooking the longer-term opportunity. In the case of Turkcell (NYSE:TKC), that's a very difficult question to answer. On one hand, the company's improving post-paid subscriber base and generally more rational competition bode well for profits. On the other hand, Turkey is going through a very dangerous time and the the squabbling between Turkcell's major shareholders have prevented the company from paying a dividend for multiple years now. When Grown-Ups Act Like ChildrenThe biggest issue for Turkcell is that its major shareholders do not get along in the slightest. It is a complicated situation with a lot of history, but the gist of it as is follows. More than half (51%) of the shares of Turkcell are owned by Turkcell Holding – a consortium owned by TeliaSonera (Nasdaq:TLSNY) (47%) and Cukurova Holdings (47%), which is in turn owned by Cukurova (51%) and Altimo (49%). Unfortunately, Cukurova took out a loan from Altimo years back and used its 13.8% net stake in Turkcell as collateral. Cukurova defaulted and Altimo has claimed that the stake belongs to them. Cukurova has argued that they should have the right to repay the loan and reclaim the stake, the U.K. Privy Council has agreed (and why a U.K. body even gets a say is another long story...). SEE: The Value Investors Handbook The long and short of it is this – control of Turkcell Holding (which is the majority owner of Turkcell) is up in the air and none of the parties are willing to agree upon a proxy representative and allow an annual shareholder meeting to occur. As such, there can be no dividend payment. While the Privy Council's ruling in favor of Cukurova back in January was thought to pave the way to a resolution, that proved a vain thought – TeliaSonera has filed suit against Cukurova in New York for over $1 billion in damages and the Privy Council has not yet decided the interest that Cukurova owes Altimo, nor is it certain that Cukurova can afford the total bill which is likely to be in excess of $2 billion. In theory, this could all be resolved quickly. There have been two failed shareholder meeting attempts this year, and Turkish law states that the Capital Markets Board can name independent directors “if the governance of the board is not functioning”. Unfortunately, this law seems to be more of a theoretical instrument designed to threaten/cajole companies into better governance. It has never, to my knowledge, been implemented and it seems like Turkish officials aren't quite sure how to proceed. With the Privy Council not likely to rule on the interest question before August, it may be difficult to resolve this situation and have a shareholder meeting unless the government steps up, and suffice it to say the Turkish government has more pressing issues today. The Base Business Is Getting BetterTurkcell has certainly taken its licks in the market. Vodafone (NYSE:VOD) and Avea (owned by Turk Telecom) have competed fiercely on price, and regulatory changes have generally been quite adverse for Turkcell. Along those lines, new on-net tariffs represent yet another threat to Turkcell's 50%+ market share. But things are looking up. Revenue rose 13% back in the first quarter on a 9% increase in ARPU and the first increase in revenue per minute (up almost 2%) in many years). Likewise, EBITDA was up 15%. Importantly, Turkcell is doing a very good job of recruiting post-paid customers (where ARPUs are 25% to 30% higher) and getting more high-value 3G/smartphone subscribers. Smartphone penetration is still below 15% in Turkey, but Turkcell has a great network. Turkcell's download speed is not only 3x better than that of Vodafone or Avea, but is actually twice that of the 4G networks of Verizon Wireless (co-owned by Verizon (NYSE:VZ)) and AT&T (NYSE:T). Couple that with only 38% nationwide penetration of post-paid plans, and I believe Turckell is well-placed to benefit from an increase in the most valuable Turkish mobile subscribers. It also doesn't hurt that Turkcell's rivals have substantially lower margins and have realized that they cannot afford to compete with cut-rate pricing indefinitely. The Bottom LineIf investors want to take advantage of the turbulence and worry in Turkey, I'd suggest buying the iShares Turkey (NYSE:TUR) ETF before Turkcell. That said, I do think Turkcell is meaningfully undervalued. On the basis of just mid-single digit revenue growth, I believe Turkcell is worth more than $16 per share today, and that does not include the possibility of upwards of $1.5 billion in cash (or nearly $2 per share) going back to shareholders in dividends once the ownership situation is resolved. Likewise, I think the company will pay a dividend around 4% on an ongoing basis. It's up to each investor if that's enough compensation for the hassle. Sooner or later this situation will be resolved, Turkcell will have its meeting, and dividends will be declared. In the meantime, it is likely that the shareholder drama and the backdrop of political instability in Turkey will overshadow the operating improvements at the company. Disclosure – As of this writing, the author owns shares of Turkcell.

Related Articles
  1. Mutual Funds & ETFs

    ETF Analysis: ALPS Medical Breakthroughs

    Learn more about a unique and innovative exchange-traded fund (ETF) in the biotechnology industry: the ALPS Medical Breakthroughs Fund.
  2. Mutual Funds & ETFs

    ETF Analysis: iShares US Healthcare

    Learn about the iShares U.S. Healthcare exchange-traded fund, which invests in a wide range of health care providers, hospitals and home care facilities.
  3. Mutual Funds & ETFs

    Top 5 Japan Mutual Funds

    Discover five of the most popular and best-performing mutual funds offering investors direct exposure to equities of Japanese companies.
  4. Mutual Funds & ETFs

    ETF Analysis: BioShares Biotechnology Clinical Trials

    Learn more about the BioShares Biotechnology Clinical Trials Fund, a new and innovative fund focusing on breakthroughs in the health industry.
  5. Mutual Funds & ETFs

    ETF Analysis: First Trust NYSE Arca Biotech

    Learn more about the First Trust NYSE Arca Biotechnology Fund, a highly rated exchange-traded fund in the biotech space.
  6. Mutual Funds & ETFs

    ETF Analysis: PowerShares KBW Bank

    Consider an examination and analysis of the PowerShares KBW Bank Portfolio ETF, considered one of the primary financial sector ETFs.
  7. Chart Advisor

    3 Ways to Trade the Rising Volatility

    With volatility increasing in the markets, many are turning to these three volatility-capturing exchange-traded products.
  8. Mutual Funds & ETFs

    ETF Analysis: iShares US Basic Materials

    Learn about the iShares US Basic Materials exchange-traded fund, which invests in the equities of chemicals, metals and industrial gas companies.
  9. Mutual Funds & ETFs

    ETF Analysis: Ultra Oil & Gas

    Find out more about the ProShares Ultra Oil & Gas exchange-traded fund, the characteristics of the ETF and the suitability and recommendations for the fund.
  10. Mutual Funds & ETFs

    ETF Analysis: PowerShares DB Commodity Tracking

    Find out about the PowerShares DB Commodity Tracking ETF, and explore a detailed analysis of the fund that tracks 14 distinct commodities using futures contracts.
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Exchange-Traded Fund (ETF)

    A security that tracks an index, a commodity or a basket of assets ...
  3. Exchange-Traded Mutual Funds (ETMF)

    Investopedia explains the definition of exchange-traded mutual ...
  4. BlackBerry Ltd

    Blackberry – formerly known as Research in Motion (RIM) – is ...
  5. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  6. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. What does a high turnover ratio signify for an investment fund?

    If an investment fund has a high turnover ratio, it indicates it replaces most or all of its holdings over a one-year period. ... Read Full Answer >>
  5. Does index trading increase market vulnerability?

    The rise of index trading may increase the overall vulnerability of the stock market due to increased correlations between ... Read Full Answer >>
  6. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>

You May Also Like

Trading Center

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!